Patents Assigned to Transcend Cytotherapy Co., Ltd
  • Method for using small molecule compounds to induce human tumor cells to be directly reprogrammed into non-oncogenic cells
    Patent number: 10463641
    Abstract: The disclosure includes a method of inducing direct reprogramming (transdifferentiation) into non-oncogenic cells accompanied by tumor cell apoptosis in human tumor cells using a small molecule composition, based on the mechanism of chemical-induction of direct cellular reprogramming. The disclosure also includes a small molecule composition used for the method, and culture media and agents prepared from the composition.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: November 5, 2019
    Assignee: Transcend Cytotherapy Co., Ltd
    Inventors: Pei-Lin Zhang, Hong-Yang Wang